Aztreonam For Injection Usp 1 Gm,500gm ,250Gm Dry Powder Injections Vial

What is Aztreonam for Injection?

Aztreonam for Injection USP is a dry powder antibacterial formulation containing aztreonam, a monobactam antibiotic used to treat selected infections caused by susceptible Gram-negative bacteria. Its clinical use depends on the infecting organism, antimicrobial susceptibility results and the approved product information. It is intended for use under qualified healthcare supervision

Uses / Indications

Aztreonam may be prescribed by healthcare professionals for susceptible bacterial infections, including certain:

• Urinary tract infections.

• Lower respiratory tract infections.

• Bloodstream infections and septicaemia.

• Skin and skin-structure infections.

• Intra-abdominal infections.

• Gynaecological infections.

The approved indications vary by product and market. Treatment should be guided by the relevant product information and, where available, culture and susceptibility results.

6. Benefits

• Provides targeted antibacterial activity against susceptible Gram-negative bacteria.

• Belongs to the monobactam class of antibiotics.

• Offers a parenteral formulation for use in appropriate clinical settings.

• May be considered by clinicians when selecting antibacterial treatment according to the patient’s condition and susceptibility findings.

Clinical outcomes depend on the organism, infection site, patient factors and appropriate prescribing.

7. Side Effects

Possible adverse effects may include:

• Rash or other hypersensitivity reactions.

• Gastrointestinal symptoms, including nausea or diarrhoea.

• Injection-site discomfort or inflammation.

• Changes in liver enzyme results.

• Other adverse reactions described in the approved product information.

Seek urgent medical assessment for signs of a serious allergic reaction. This list is not exhaustive.

8. How Does It Work?

Aztreonam is a bactericidal antibiotic that acts by interfering with bacterial cell-wall synthesis. Its activity is directed primarily against susceptible aerobic Gram-negative bacteria. It does not replace the need for microbiological assessment or appropriate antimicrobial selection.

9. Dosage Guidelines

• The dose and treatment duration must be determined by a qualified healthcare professional.

• Dosage depends on the infection, its severity, the causative organism and the patient’s clinical condition.

• Kidney function and other relevant patient factors may affect prescribing decisions.

• Preparation, dilution and administration must follow the approved product-specific instructions.

Do not use a generic preparation or dosing instruction in place of the approved leaflet for the exact product and strength.

10. When Not to Use

Aztreonam should not be used in patients with a known serious hypersensitivity to aztreonam or any component of the specific formulation, unless a specialist determines otherwise in accordance with the applicable product information.

Before treatment, the prescriber should review the patient’s allergy history, medical conditions and current medicines.

11. Drug / Product Interactions

The healthcare professional should review all prescription medicines, non-prescription products and other antibiotics being used.

• Concurrent antibacterial therapy should be selected according to clinical need.

• Laboratory monitoring may be appropriate depending on the patient’s condition and concomitant medicines.

• Do not mix Aztreonam with another medicine in the same container or infusion line unless compatibility is confirmed by an authorised reference.

Refer to the approved product information for the complete interaction and compatibility details.

12. Safety Advice

• For professional use under qualified healthcare supervision.

• Use only for infections for which antibacterial treatment is clinically appropriate.

• Follow the prescribed dose, route and duration.

• Report any suspected allergic reaction or serious adverse effect promptly.

• Avoid unnecessary antibiotic use to help reduce antimicrobial resistance.

  

  DailyMed

  +1

13. General Instructions

• Verify the product name, strength, batch details and expiry date before use.

• Inspect the vial and packaging for damage or signs of tampering.

• Reconstitute and administer only according to the approved product-specific instructions.

• Do not use a prepared solution if its appearance does not meet the product specification.

• Follow the applicable procedures for aseptic preparation and disposal.

14. Special Dietary / Lifestyle Tips

There is no universal dietary plan specific to aztreonam injection. Patients should follow the advice of their treating healthcare professional, maintain adequate hydration where clinically appropriate and report persistent diarrhoea or other concerning symptoms.

Dietary or lifestyle measures do not replace prescribed antibacterial treatment.

15. Comparison with Other Treatments

These medicines are not automatically interchangeable. The choice depends on infection type, culture results, resistance patterns, patient allergies and local treatment guidance.

16. Precautions & Warnings

• Confirm any history of antibiotic hypersensitivity before treatment.

• Use caution and appropriate monitoring in patients with impaired kidney function.

• Monitor for severe allergic reactions and clinically significant adverse effects.

• Use antibiotics only when a bacterial infection is proven or strongly suspected.

• Strengths, approved indications, preparation instructions and storage conditions must be verified against the exact product’s authorised documentation.

  

  DailyMed

  +1

17. Can I Use It With Other Medicines or Antibiotics?

Aztreonam may be prescribed alongside other treatments when clinically indicated, but combination therapy must be assessed by the treating healthcare professional. Do not start, stop or combine antibiotics without medical advice. Compatibility should be verified before any medicines are mixed or administered together.

18. Storage

Store the unopened product according to the storage conditions printed on the approved product label. Protect it from unsuitable environmental conditions and keep it in its original packaging as directed.

Do not apply a storage temperature or prepared-solution shelf life from another manufacturer’s product without confirming it against the specific formulation.

19. Frequently Asked Questions

1. What is Aztreonam for Injection used for?

It is used to treat certain infections caused by susceptible Gram-negative bacteria, according to the approved product information and clinical assessment.

2. What type of antibiotic is aztreonam?

Aztreonam belongs to the monobactam class of beta-lactam antibiotics.

3. Which strengths are listed for this product?

The supplied information lists 1 g, 500 and 250. The latter two should be confirmed as 500 mg and 250 mg before the product page is published.

4. Is Aztreonam for Injection suitable for every bacterial infection?

No. Its activity is limited to susceptible organisms, and it is not appropriate for every bacterial infection.

5. Can the injection be prepared without checking the product leaflet?

No. Preparation and administration must follow the approved instructions for the exact product and strength.

6. Can Aztreonam be used with other antibiotics?

Combination treatment may be appropriate in selected cases, but the decision must be made by a qualified healthcare professional.

7. What packing is available?

Packing details are available on request and should be confirmed with the supplier.

8. What storage conditions apply?

Use the storage conditions stated on the approved label for the specific product. Do not assume that instructions for another aztreonam product are identical.